Indonesia University: Diabetes Mellitus, Type 2 trials

The registry lists 13 Diabetes Mellitus, Type 2 studies with Indonesia University as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 4Phase 4 2No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Mesenchymal Stromal/Stem Cells-Derived Exosomes (MSC-Exos) Therapy for Type 2 Diabetes Mellitus PatientsNot yet recruitingNCT07144241Phase 2
• The Effect of Propolis Administration on Cholesterol Level in Diabetic Type 2 PatientsRecruitingNCT06903546Phase 4
• Umbilical Cord Mesenchymal Stem Cell Secretome Administration in Severe Erectile Dysfunction Non-responsive to SildenafilCompletedNCT07245875Not applicable
• Carbohydrate Loading in Type 2 Diabetes MellitusCompletedNCT06687811Not applicable
• Integration of Health Coaching and Diabetes Education in Type 2 Diabetes Mellitus Management at Primary Health CareStatus unknownNCT05090488Not applicable
• Cholecalciferol on Depressive Symptoms in Type 2 Diabetes Mellitus PatientsStatus unknownNCT04917458Phase 2
• BM-MNC and UCMSC for Type 2 Diabetes Mellitus PatientsStatus unknownNCT04501341Phase 1/2
• The Effectiveness of "CARE Coaching Model" as an Effort to Empower Type 2 Diabetes Mellitus PatientsCompletedNCT04289818Not applicable
• Integration of Education Based-Application and "CARE Coaching Model" in Management of Type 2 Diabetes Mellitus Patients Using InsulinStatus unknownNCT04271631Not applicable
• Effect of Centella Asiatica on Xerotic Skin in Diabetes Mellitus Type 2Status unknownNCT03815305Phase 4
• Development of Structured Exercise Program for T2DM ManagementCompletedNCT03563456Not applicable
• Effects of Olive Oil and Bran Oil on Antioxidant Levels, Glycemic Control, and Lipid Profile in Patient Type 2 DMCompletedNCT03544411Phase 1
• Immunogenicity Study of Insulin Glargine Ezelin vs Lantus in Type 2 Diabetes Mellitus PatientsCompletedNCT03352674Phase 2